Bariatric surgery is reported to be less costly than GLP-1 drugs over a two-year period. The comparison between bariatric surgery and GLP-1 drugs is being explored in terms of costs and outcomes, with some studies suggesting surgery may be more effective. The rise of GLP-1 medications may be impacting the volume of bariatric surgeries, but the relationship between these treatments and their implications for patient care is still being examined.